Become a Member

Topic Archives: aspirin

Articles

  • June 22, 2019 / onstadmichael

    written by reader Undervalued Bayer AG ADR, Is it worth buying at such a low valuation given the recent legal trouble from Monsanto “roundup” products

    Hi, Looking to gain thoughts/opinions on Bayer & if anyone thinks this company is temporarily undervalued from the recent media surrounding the lawsuits from ”roundup” products. It certainly looks appealing compared to other big pharma companies. Also interested in any thoughts on investing in companies that gain profits from selling products like roundup, which is […]

    Leave a comment Read More
  • December 19, 2018 / Michael Jorrin, "Doc Gumshoe"

    Trying to Make Sense of Puzzling Health-Care News

    Musings from Doc Gumshoe: Aspirin, ADHD, CRISPR and more...

    13 Comments Read More

    • Comments

  • doc5653 on “If I Had to Pick One Stock to Retire On, I’d Pick this…” / Oct 23, 2:00pm

    Captain Crunch and Lucky Charms. Chock full of magical ingredients with no documented scientific basis. As long as you...

    Read More
  • david on What’s Stansberry teasing as “America’s New Energy?” / Oct 17, 4:05am

    have you ever check to see how many of these newsletter pitches meet or even come close to the gains they say are possi...

    Read More
  • Steve on written by reader The Next Aspirin / Oct 29, 11:26pm

    This is not the new “aspirin” pre ipo. Emerald was given a while back....

    Read More
  • Randeep on written by reader The Next Aspirin / Sep 14, 1:09pm

    Guys, no offense but I think we all are smarter than this... are you guys seriously searching with “aspirin” name ? ...

    Read More
  • Charles Fox on written by reader The Next Aspirin / Sep 14, 11:57am

    Teeka indicated that the candidate company has EU orphan drug status as well. Vitalis has no mention in the EU list. Eme...

    Read More
  • derek54 on written by reader The Next Aspirin / Sep 14, 9:54am

    I think I have found it also. Did an FDA "aspirin" search and Vitalis out of New York came up with Orphan drug status. ...

    Read More
  • garyb014 on written by reader 76,000% gain. Teeka Tiwari’s latest pitch. / Sep 12, 2:13pm

    So I watched the whole thing again. It’s called the next aspirin because it is taking the same pathway as aspirin by t...

    Read More
  • truman1956 on written by reader 76,000% gain. Teeka Tiwari’s latest pitch. / Sep 11, 3:28pm

    I dont think its EHT. I watched the same seminar. He says its making the next aspirin....

    Read More
  • J Thomas on Brief Bulletins of Interest / Mar 4, 9:54am

    "The principal risk associated with aspirin is bleeding in the GI tract...".I used to get sporadic nose bleeds as a ki...

    Read More
  • niizajim on What’s this “One Stock for the First Addiction-Proof Cure for Pain?” / Feb 7, 7:22pm

    A stock that this "resident doctor" you mentioned recommended in the past in this space was Antibe Therapeutics. I have...

    Read More
  • jimh981 on Looking Backward – And a Peek in the Other Direction / Jan 31, 4:07pm

    The discussion of Epidiolex caused me to wonder what Docc Gumshoe's thoughts are on OTC hemp oil CBDs. I have friends w...

    Read More
  • ET69 on Trying to Make Sense of Puzzling Health-Care News / Dec 19, 12:42pm

    Thanks MJ, This is the real reason I read stockgumshoe.Having worked in the “Health care” profession for decad...

    Read More

    • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info